v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash Flows from Operating Activities    
Net (loss) income $ (14,370,270) $ 2,289,894
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Gain on cash (investments) held in Trust Account (1,029,273) (3,290,543)
Change in fair value of derivative warrant liabilities 14,012,341 (404,375)
Change in fair value of conversion option 868,338
Changes in operating assets and liabilities:    
Prepaid expenses 10,306 70,495
Deferred legal fees 113,325 408,166
Accounts payable 90,944 14,878
Due from related party 42,074
Due to related party (165,000) 95,000
Accrued expenses (2,200) 63,996
Net cash used in operating activities (429,415) (752,489)
Cash Flows from Investing Activities    
Trust Account withdrawal – redemption 57,089,949 30,440,234
Extension contribution deposit into Trust Account (935,771) (1,140,000)
Net cash provided by investing activities 56,154,178 29,300,234
Cash Flows from Financing Activities    
Redemption of Class A ordinary shares (57,089,949) (30,440,234)
Proceeds from Promissory note – working capital loan 436,202 753,420
Proceeds from Promissory note – extension loan 935,769 1,140,000
Net cash used in financing activities (55,717,978) (28,546,814)
Net increase in cash 6,785 931
Cash - beginning of period 1,173 1,253
Cash - end of period 7,958 2,184
Supplemental disclosure of noncash investing and financing activities:    
Remeasurement of Class A ordinary shares to redemption value 1,180,670 4,430,552
Extension contribution due from Sponsor $ 151,395 $ 360,000